Status:
COMPLETED
Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia
Lead Sponsor:
Ohio State University
Collaborating Sponsors:
Roche Diagnostics GmbH
Conditions:
Preeclampsia Severe or Mild
Cardiac Complication
Eligibility:
FEMALE
18+ years
Brief Summary
The investigators plan to enroll women with PE prospectively to evaluate incremental cardiovascular risk in those who have PE with severe features. This study includes detailed echocardiographic evalu...
Detailed Description
Preeclampsia (PE) is a multi-system progressive disorder affecting up to 8% of pregnancies. Epidemiologic studies have shown a significant association between PE and future cardiovascular disease (CVD...
Eligibility Criteria
Inclusion
- Females older than 18 years of age
- Singleton pregnancy
- The patient is physically and mentally able to understand the informed consent and is willing to participate in this study
- Able to speak English
- Must meet one of the population categories, until each group has reached 20 subjects
Exclusion
- Multiple gestation
- History of chronic hypertension or cardiac disease including but not limited to history of heart arrhythmias, congenital heart disease, and use of any cardiac medication (such as beta blockers, ACE inhibitors, calcium channel blockers) prior to pregnancy.
- History of medical problems that may contribute to cardiac dysfunction, including but not limited to chronic hypertension, poorly controlled hyperthyroidism and diabetes mellitus.
Key Trial Info
Start Date :
August 19 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 14 2023
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04063397
Start Date
August 19 2019
End Date
December 14 2023
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43210